Data is the most important asset in today’s biopharma R&D industry as organizations increasingly adopt data-driven operations. Traditional systems such as ELNs, LIMS, or other ad-hoc solutions are not able to keep up with the increasing complexity of novel therapeutic modalities and the growing use of automation. Organizations need a flexible and open, yet fully integrated solution to connect their large and complex R&D operations. The solution needs to simultaneously provide a robust and scalable digital backbone that can integrate fragmented IT landscapes and evolve as new R&D workflows and technologies are adopted.
This is where Genedata comes in.